title: The role of 99mTc-tetrofosmin brain SPECT in differentiating treatment-induced necrosis from recurrent brain tumor.
authors.forename: George A
authors.initials: GA
authors.lastname: Alexiou
authors.forename: Andreas D
authors.initials: AD
authors.lastname: Fotopoulos
authors.forename: Spyridon
authors.initials: S
authors.lastname: Tsiouris
authors.forename: Spyridon
authors.initials: S
authors.lastname: Voulgaris
authors.forename: Athanasios P
authors.initials: AP
authors.lastname: Kyritsis
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D001927:Brain Diseases / Q000000981:diagnostic imaging*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D008297:Male; D009336:Necrosis / Q000209:etiology*; D009364:Neoplasm Recurrence, Local / Q000209:etiology*; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D011832:Radiation Injuries / Q000150:complications*; D019275:Radiopharmaceuticals; D015899:Tomography, Emission-Computed, Single-Photon / Q000379:methods*
chemical_list: D000970:Antineoplastic Agents; D009943:Organophosphorus Compounds; D015609:Organotechnetium Compounds; D019275:Radiopharmaceuticals